PRICE T ROWE ASSOCIATES INC /MD/ - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$62,000
-53.0%
60,400
-36.9%
0.00%
Q2 2021$132,000
-23.7%
95,700
-5.9%
0.00%
Q1 2021$173,000
+16.1%
101,725
+77.8%
0.00%
Q4 2016$149,000
+156.9%
57,200
+163.4%
0.00%
Q2 2016$58,000
-14.7%
21,718
-1.4%
0.00%
Q1 2016$68,000
-69.8%
22,018
-62.3%
0.00%
Q4 2015$225,000
+5.1%
58,346
+49.8%
0.00%
Q3 2014$214,000
-46.4%
38,9370.0%0.00%
Q2 2014$399,000
-44.4%
38,937
-34.8%
0.00%
Q1 2014$717,00059,7350.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders